Introduction 7.78329
:Ċ 7.2464776
Mel 8.964659
an 0.73436916
oma 0.49195936
, 3.485793
Ġa 1.5291072
Ġform 3.153481
Ġof 0.0038832151
Ġskin 0.26376
Ġcancer 0.010057439
, 0.32324338
Ġhas 2.994547
Ġexperienced 7.7239075
Ġsignificant 3.7162805
Ġadvancements 3.491733
Ġin 0.2878554
Ġtreatments 5.251414
Ġin 2.321115
Ġrecent 0.874489
Ġyears 0.07381855
. 0.4004847
ĠAmong 5.504305
Ġthese 1.4764986
Ġadvancements 1.2550324
, 1.2798115
Ġimmune 4.131886
Ġcheckpoint 0.49192178
Ġinhibitors 0.34822565
Ġand 3.9620285
Ġad 5.817974
ju 0.007335314
vant 0.009260735
Ġtherapies 1.6095439
Ġhave 0.44338837
Ġemerged 3.392373
Ġas 0.105043165
Ġpromising 1.7183428
Ġapproaches 3.792787
. 2.0862236
ĠThis 3.309358
Ġessay 7.409493
Ġexplores 3.985871
Ġthe 0.40478724
Ġpotential 3.1039553
Ġbenefits 2.766561
Ġof 0.5877181
Ġthese 2.1152291
Ġtreatments 1.8707889
, 2.2581348
Ġtheir 3.408227
Ġimplications 6.083008
Ġfor 0.69209605
Ġpatients 2.964007
Ġat 6.3016376
Ġdifferent 2.9192667
Ġstages 0.32731223
Ġof 0.11980326
Ġmelan 1.3851237
oma 0.0034167706
, 0.7573721
Ġand 0.12746094
Ġtheir 1.9752321
Ġimpact 3.572826
Ġon 0.036375266
Ġimproving 5.0215764
Ġsurvival 2.7113976
Ġrates 1.125288
. 1.2176514
ĠFurthermore 3.7621865
, 0.003200647
Ġit 1.6133505
Ġwill 2.4721065
Ġdraw 6.7482433
Ġon 2.0135865
Ġresearch 4.154418
Ġevidence 3.8374326
Ġand 2.1613252
Ġanalyze 8.045797
Ġthe 0.6017073
Ġcase 7.499651
Ġof 0.8593
ĠMr 7.0163193
. 0.084380284
ĠB 4.617461
Ġas 5.0853105
Ġan 1.1750573
Ġillustr 4.085049
ative 0.0004189946
Ġexample 1.2240468
.Ċ 1.7647548
Body 6.7847834
:Ċ 1.9727633
I 5.4705067
. 0.29673323
ĠImm 2.185319
une 0.00881417
ĠCheck 0.8734093
point 0.057224303
ĠIn 0.078702934
hib 0.009743694
itors 0.0770672
:Ċ 2.1407433
A 2.18689
. 0.038414042
ĠMechan 3.5082884
ism 0.35291424
Ġof 0.20121741
ĠAction 0.11191777
:Ċ 0.558622
Imm 1.3173954
une 0.0043644905
Ġcheckpoint 0.32817298
Ġinhibitors 0.1663639
, 2.3650682
Ġsuch 1.6781592
Ġas 0.0012227283
Ġpemb 2.6786456
rol 0.0012686859
iz 0.0018923414
um 0.0025848162
ab 0.00148772
Ġand 0.6571004
Ġn 0.20337549
iv 0.0036257238
olum 0.00095517095
ab 0.00094849925
, 0.06148678
Ġaim 5.365287
Ġto 0.038835656
Ġenhance 3.8164568
Ġthe 0.44308165
Ġbody 1.5283201
's 2.419745
Ġimmune 0.88287836
Ġresponse 0.6442126
Ġagainst 1.1692392
Ġmelan 2.7274365
oma 0.022627877
Ġcells 0.8877734
Ġby 1.114278
Ġblocking 1.8488522
Ġthe 0.8271528
Ġsuppress 7.1379304
ive 0.49109617
Ġsignals 3.5813913
Ġimposed 9.185492
Ġby 0.16051951
Ġspecific 5.5055876
Ġimmune 1.322762
Ġcheckpoints 0.8175523
, 2.1112547
Ġlike 5.6308966
ĠPD 0.90322375
- 0.29100612
1 0.0007934243
/P 2.463256
D 0.023885174
-L 0.014618359
1 0.00793085
Ġand 1.3976586
ĠCTL 0.16718107
A 0.0005436193
- 0.06157085
4 0.00011284107
.Ċ 2.6024528
B 1.3318374
. 0.010349488
ĠEffect 4.991787
iveness 0.8233235
Ġand 2.5262628
ĠLong 6.3564024
-term 1.9628327
ĠRem 6.0001974
ission 0.15808657
:Ċ 1.3469249
Research 5.6727695
Ġhas 1.0167055
Ġshown 0.57643956
Ġsubstantial 8.02772
Ġpromise 4.7657766
Ġin 0.76150435
Ġimmune 4.511868
Ġcheckpoint 0.24512333
Ġinhibitors 0.6167528
, 1.6163993
Ġleading 4.278699
Ġto 0.08092262
Ġimpressive 4.64464
Ġresponse 3.801816
Ġrates 0.03343048
Ġand 1.5385562
Ġdurable 3.7594995
, 4.2098036
Ġlong 0.39194554
-term 0.22958839
Ġrem 0.48439136
ission 0.56935626
Ġin 1.0384481
Ġpatients 1.2251824
Ġwith 0.18604569
Ġadvanced 0.9370166
Ġmelan 0.21407491
oma 0.013702088
. 0.4721988
ĠClinical 5.547606
Ġtrials 0.4689342
Ġdemonstrated 4.8991957
Ġa 2.4665713
Ġsignificant 2.754484
Ġsurvival 2.616868
Ġadvantage 1.306441
Ġfor 1.2420788
Ġpatients 0.3720249
Ġtreated 1.5058101
Ġwith 0.017692469
Ġpemb 2.7239804
rol 0.0008594119
iz 0.0014552361
um 0.0009657728
ab 0.00018792471
Ġand 1.6553068
Ġn 0.054706797
iv 0.0034936387
olum 0.0005654226
ab 0.0005643534
Ġcompared 1.44556
Ġto 0.20480263
Ġtraditional 5.073889
Ġtherapies 1.9701278
.Ċ 2.4711483
C 0.7831739
. 0.0039870967
ĠImp 3.026667
lications 0.06396112
Ġfor 0.37407413
ĠPatients 0.31254035
Ġat 2.0848622
ĠDifferent 0.039985936
ĠSt 0.013989784
ages 0.00025621374
:Ċ 1.8967321
1 5.3642507
. 0.16874254
ĠAdvanced 3.6520119
ĠMel 2.4448
an 0.00032664477
oma 0.012378375
: 1.5905318
ĠImm 1.5803053
une 0.0028531365
Ġcheckpoint 0.0591719
Ġinhibitors 0.06599358
Ġhave 0.90525115
Ġproven 2.7185326
Ġparticularly 4.2794647
Ġeffective 0.4454796
Ġin 0.30607003
Ġpatients 0.89665383
Ġwith 0.14972281
Ġadvanced 0.33945692
Ġor 4.3082805
Ġmetast 0.104663186
atic 0.00407389
Ġmelan 0.063297
oma 0.011322138
, 1.531106
Ġachieving 5.5205765
Ġhigher 5.34886
Ġresponse 0.6855754
Ġrates 0.02075489
Ġand 0.7699331
Ġsuperior 4.390785
Ġoverall 1.1365469
Ġsurvival 0.046250876
Ġcompared 1.1717628
Ġto 0.0545008
Ġstandard 1.8559659
Ġtreatments 2.1606507
.Ċ 1.3672771
2 0.2559646
. 0.003418674
ĠEarly 2.801792
-stage 2.006794
ĠMel 0.43852502
an 0.0001627764
oma 0.0032477048
: 0.15177637
ĠStudies 3.5723367
Ġare 4.346684
Ġunderway 1.890849
Ġto 0.25856674
Ġinvestigate 2.6524801
Ġthe 0.3546205
Ġpotential 1.8966908
Ġrole 2.3016787
Ġof 0.042775467
Ġimmune 0.16800797
Ġcheckpoint 0.04113786
Ġinhibitors 0.0633534
Ġin 0.1382649
Ġad 7.7868886
ju 0.000108788154
vant 0.0012541615
Ġtherapy 0.8015
Ġsettings 5.894322
, 1.5683991
Ġwhich 3.3780067
Ġmay 1.9072033
Ġimprove 2.4270778
Ġoutcomes 2.3104784
Ġand 2.8598661
Ġreduce 1.2676655
Ġrecurrence 2.2151928
Ġrates 0.76057744
Ġin 1.0967698
Ġpatients 0.53554755
Ġwith 0.35513622
Ġearlier 5.6558146
Ġstages 1.618937
Ġof 0.10197649
Ġmelan 0.30035862
oma 0.0040903934
.Ċ 0.341289
II 2.9070575
. 0.0062122205
ĠAd 0.18436424
ju 4.9663133e-05
vant 0.0015076012
ĠTher 2.817567
ap 0.005269446
ies 0.00028767617
:Ċ 0.08169269
A 0.07591256
. 0.0030370129
ĠCombination 8.296126
ĠTher 2.778685
ap 0.002082455
ies 9.0073176e-05
:Ċ 0.41523522
Com 3.795937
binations 0.03689702
Ġof 0.0729972
Ġimmune 0.45024392
Ġcheckpoint 0.022984782
Ġinhibitors 0.038996413
Ġwith 1.0802263
Ġother 0.98928857
Ġad 2.3858662
ju 7.703444e-06
vant 0.0119186025
Ġtherapies 0.26659015
, 1.7167575
Ġsuch 0.20765136
Ġas 0.0018543887
Ġtargeted 3.5562239
Ġtherapies 0.5863164
Ġor 1.980752
Ġradio 3.2304528
therapy 0.08694197
, 0.057717726
Ġshow 4.460803
Ġpotential 3.513442
Ġin 1.8619528
Ġimproving 0.7487999
Ġtreatment 3.740961
Ġoutcomes 0.19412293
Ġand 1.490375
Ġpreventing 4.572473
Ġtumor 3.4498034
Ġrel 2.707694
apse 0.038804695
.Ċ 0.96578
B 0.14901757
. 0.0017050558
ĠEffect 4.4396563
iveness 0.0544404
Ġin 2.4254856
ĠRed 5.919959
ucing 0.0006190312
ĠRec 0.3483306
urrence 0.025240991
:Ċ 0.8838057
Clinical 4.2428904
Ġtrials 0.37470546
Ġhave 0.6128424
Ġillustrated 7.3616815
Ġthe 1.2249458
Ġeffectiveness 1.9935565
Ġof 0.044274904
Ġad 2.0773022
ju 1.2948405e-05
vant 0.00043567579
Ġtherapies 0.83984256
Ġin 0.3454494
Ġsignificantly 6.730912
Ġreducing 0.24064414
Ġthe 0.9439199
Ġrisk 0.8163847
Ġof 0.02366364
Ġrecurrence 0.6569936
Ġin 1.0304399
Ġpatients 0.28777555
Ġwith 0.102153026
Ġhigh 4.1996865
-risk 0.12514888
Ġmelan 0.5456007
omas 2.92622
Ġafter 5.5264883
Ġsurgical 2.3740807
Ġremoval 1.3731139
.Ċ 1.1930373
C 0.4374123
. 0.0015878199
ĠImp 1.4645226
lications 0.05340575
Ġfor 0.04245995
ĠPatients 0.07118361
Ġat 0.32949778
ĠDifferent 0.0098203095
ĠSt 0.004050502
ages 0.00023083435
:Ċ 0.04866787
1 0.11025852
. 0.0028393494
ĠIntermediate 5.4252024
Ġto 5.0510015
ĠHigh 0.33075327
-risk 1.0542116
ĠMel 0.2598236
an 9.293406e-05
oma 0.664533
: 0.1302147
ĠAd 2.0199032
ju 0.00016849818
vant 0.0007326745
Ġtherapies 0.4375634
Ġhave 1.3296365
Ġshown 1.4164615
Ġpromising 1.0871522
Ġresults 0.4430939
Ġin 0.20460708
Ġimproving 2.5805933
Ġsurvival 1.879873
Ġrates 0.7820539
Ġand 0.99885625
Ġprolong 4.9117866
ing 0.008819606
Ġrem 2.6885474
ission 0.07962972
Ġin 1.1168125
Ġpatients 0.2810553
Ġat 3.558213
Ġintermediate 1.1258268
Ġto 0.81000036
Ġhigh 0.028767025
-risk 0.16389781
Ġstages 1.149591
Ġof 0.1335693
Ġmelan 0.043013234
oma 0.010363172
, 2.322204
Ġreducing 4.8904037
Ġthe 0.5708833
Ġchances 4.320811
Ġof 0.022992121
Ġrecurrence 1.3388594
Ġand 1.0603037
Ġdisease 4.5100975
Ġprogression 0.23108138
.Ċ 0.25182715
2 0.09835524
. 0.0021226613
ĠLow 0.88984627
-risk 0.36803564
ĠMel 0.059649076
an 0.00028338484
oma 0.07645791
: 0.035182387
ĠThe 3.2066236
Ġrole 2.2813017
Ġof 0.021762272
Ġad 0.25771034
ju 3.1737043e-06
vant 0.0008198729
Ġtherapies 0.2045718
Ġin 0.5352107
Ġlow 1.3383006
-risk 0.040571164
Ġmelan 0.22741316
oma 0.80173385
Ġis 0.865976
Ġnot 2.9335132
Ġyet 0.81795686
Ġwell 2.0943923
-established 1.5735486
. 0.92738765
ĠMore 3.9401798
Ġresearch 0.8471688
Ġis 0.11846825
Ġneeded 0.4784926
Ġto 0.13979709
Ġdetermine 1.3611811
Ġtheir 1.9319795
Ġpotential 1.690545
Ġbenefits 1.9061776
Ġin 1.247574
Ġthis 1.2601289
Ġpatient 2.4894469
Ġpopulation 0.14852336
.Ċ 0.121183805
III 1.2898797
. 0.005769277
ĠImp 5.643773
lications 0.07362012
Ġfor 0.32887602
ĠSurvival 7.825627
ĠRates 1.0409997
Ġand 3.6476927
ĠMr 10.181777
. 0.04209039
ĠB 0.024087807
's 2.9821453
ĠCase 0.1518323
:Ċ 0.07859583
A 0.18324062
. 0.009280693
ĠImpact 4.8471847
Ġon 0.60557956
ĠSurvival 0.5914966
ĠRates 0.09943325
:Ċ 0.36951318
The 2.756781
Ġintroduction 4.549588
Ġof 0.02942123
Ġimmune 0.38062918
Ġcheckpoint 0.015688598
Ġinhibitors 0.029355133
Ġand 1.9430099
Ġad 0.4126459
ju 7.465036e-06
vant 0.00097208685
Ġtherapies 0.12698364
Ġhas 0.5045439
Ġsignificantly 1.7389522
Ġenhanced 4.4228363
Ġsurvival 1.2632178
Ġrates 0.0634805
Ġin 1.2480952
Ġpatients 0.25133485
Ġwith 0.045813255
Ġadvanced 0.48310125
Ġmelan 0.32681486
oma 0.011332629
. 0.47165018
ĠThese 3.456952
Ġtreatments 0.7818541
Ġoffer 3.7970006
Ġnew 3.8766265
Ġhope 1.2497596
Ġfor 0.7002289
Ġlong 5.1819696
-term 0.13819066
Ġrem 0.6002873
ission 0.05829896
.Ċ 3.7175393
B 0.1386097
. 0.00079413963
ĠMr 5.755215
. 0.005157385
ĠB 0.0021100515
's 0.34411454
ĠCase 0.058808126
:Ċ 0.18225451
Mr 0.575562
. 0.008221752
ĠB 0.0040345876
, 1.7990751
Ġdiagnosed 5.076885
Ġwith 0.10775612
Ġadvanced 2.0032272
Ġmelan 0.65855616
oma 0.0015888928
, 1.0081698
Ġexempl 9.172424
ifies 0.023896117
Ġthe 0.311123
Ġpotential 1.5519537
Ġof 2.8329518
Ġimmune 0.42980918
Ġcheckpoint 0.015147917
Ġinhibitors 0.060747787
Ġto 2.2252278
Ġachieve 4.3154006
Ġrem 3.254693
ission 0.04943402
. 1.655633
ĠWith 4.2483287
Ġpemb 5.4362836
rol 0.00049715186
iz 0.002330575
um 0.000274683
ab 0.00012892624
Ġtreatment 2.634723
, 0.16255991
Ġhis 2.2750125
Ġtumor 1.9026513
Ġshr 3.6019666
inks 4.2608833
Ġsignificantly 2.2709146
, 0.96310794
Ġleading 2.629515
Ġto 0.11718569
Ġincreased 5.008294
Ġoverall 2.242589
Ġsurvival 0.059422083
Ġand 1.4808674
Ġquality 4.0929966
Ġof 0.046562463
Ġlife 0.002718449
.Ċ 0.9491371
Conclusion 2.0827327
:Ċ 0.069196075
The 2.4179335
Ġadvancements 4.8304152
Ġin 0.214216
Ġimmune 0.46266514
Ġcheckpoint 0.015628746
Ġinhibitors 0.18266372
Ġand 0.42485243
Ġad 0.14192788
ju 6.2729996e-06
vant 0.0005182436
Ġtherapies 0.093896836
Ġhave 0.43886417
Ġrevolution 3.9591768
ized 0.0015024792
Ġmelan 2.3747313
oma 0.003671687
Ġtreatment 0.2842463
, 1.2074195
Ġoffering 2.8994975
Ġimproved 3.6009254
Ġsurvival 0.73961675
Ġrates 0.20374426
Ġand 0.40530422
Ġthe 5.2582426
Ġpotential 0.88995606
Ġfor 0.78524953
Ġlong 0.44897318
-term 0.056269288
Ġrem 0.017461952
ission 0.01953714
. 0.4545886
ĠThese 2.0519514
Ġtreatments 0.55424005
Ġhave 1.609383
Ġshown 3.2145817
Ġparticular 5.0976343
Ġefficacy 3.1077087
Ġin 0.18482988
Ġpatients 0.78151184
Ġwith 0.1253038
Ġadvanced 0.48856038
Ġmelan 0.74063694
oma 0.031681642
, 0.5400095
Ġwhile 4.2549696
Ġongoing 7.2307215
Ġresearch 0.716717
Ġexplores 4.891269
Ġtheir 0.7920483
Ġbenefits 3.633457
Ġfor 2.7390158
Ġpatients 0.9245136
Ġat 0.9662636
Ġearlier 2.1942892
Ġstages 0.0126422
. 1.0272638
ĠThe 2.5174687
Ġcase 1.9198214
Ġof 0.17687768
ĠMr 0.011760155
. 0.019236071
ĠB 0.0011824887
Ġfurther 5.326009
Ġdemonstrates 1.8622806
Ġthe 0.22290282
Ġprofound 5.742077
Ġimpact 0.7272404
Ġthese 1.7812445
Ġtherapies 2.0786345
Ġcan 0.4328646
Ġhave 0.015978066
Ġon 0.20198898
Ġpatients 1.2876625
' 1.3645616
Ġlives 0.7468765
, 1.4211906
Ġinspiring 5.307333
Ġhope 0.7918765
Ġfor 0.7505524
Ġa 2.4309506
Ġbrighter 1.4279519
Ġfuture 0.09763174
Ġin 3.7744853
Ġmelan 1.4500957
oma 0.006000252
Ġmanagement 3.926152
. 1.626054
